These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17708716)

  • 1. Postoperative uptake in the thyroid bed, not tumor stage, determines the usefulness of diagnostic whole body scan in the first year after ablation with radioiodine.
    Rosário PW; Barroso AL; Purisch S
    Thyroid; 2007 Aug; 17(8):803-4. PubMed ID: 17708716
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Giovanella L; Paone G; Ruberto T; Ceriani L; Trimboli P
    Endocrinol Metab (Seoul); 2019 Mar; 34(1):63-69. PubMed ID: 30784242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation.
    Thientunyakit T; Pusuwan P; Tuchinda P; Khiewvan B
    J Med Assoc Thai; 2013 Sep; 96(9):1199-207. PubMed ID: 24163997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined BRAF
    Campennì A; Ruggeri RM; Siracusa M; Pignata SA; Di Mauro F; Vento A; Trimarchi F; Baldari S
    J Endocrinol Invest; 2018 Nov; 41(11):1283-1288. PubMed ID: 29549631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan.
    Kaya M; Cermik TF
    Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear imaging in the management of thyroid carcinoma.
    Cavalieri RR
    Thyroid; 1996 Oct; 6(5):485-92. PubMed ID: 8936676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer.
    Van Nostrand D; Aiken M; Atkins F; Moreau S; Garcia C; Acio E; Burman K; Wartofsky L
    Thyroid; 2009 Aug; 19(8):849-55. PubMed ID: 19281428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental finding of hiatal hernia on (99m)Tc-sestamibi whole-body scan in thyroid cancer evaluation.
    Del Castillo-Matos R; Quirce R; Martínez-Rodríguez I; Medina-Quiroz P; Rubio-Vassallo A; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):163-4. PubMed ID: 22056002
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid Remnant Estimation by Diagnostic Dose (131)I Scintigraphy or (99m)TcO4(-) Scintigraphy after Thyroidectomy: A Comparison with Therapeutic Dose (131)I Imaging.
    Liu G; Li N; Li X; Chen S; Du B; Li Y
    Biomed Res Int; 2016; 2016():4763824. PubMed ID: 27034938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal meningioma on 99mTc-MIBI scan for postoperative evaluation of differentiated thyroid cancer.
    Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):320-1. PubMed ID: 21719159
    [No Abstract]   [Full Text] [Related]  

  • 11. The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.
    McDougall IR
    Thyroid; 2009 Aug; 19(8):811-3. PubMed ID: 19645613
    [No Abstract]   [Full Text] [Related]  

  • 12. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
    Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
    Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
    Cholewinski SP; Yoo KS; Klieger PS; O'Mara RE
    J Nucl Med; 2000 Jul; 41(7):1198-202. PubMed ID: 10914909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid stunning after (131)I diagnostic whole-body scanning.
    McMenemin RM; Hilditch TE; Dempsey MF; Reed NS
    J Nucl Med; 2001 Jun; 42(6):986-7. PubMed ID: 11390566
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical significance of diffuse hepatic visualization and thyroid bed uptake on post-ablative iodine-131 whole body scan in differentiated thyroid cancer.
    Kim K; Kim SJ; Kim IJ; Kim YK; Kim BS; Pak K
    Onkologie; 2012; 35(3):82-6. PubMed ID: 22414970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose 131I.
    Huić D; Medvedec M; Dodig D; Popović S; Ivancević D; Pavlinovic Z; Zuvic M
    Nucl Med Commun; 1996 Oct; 17(10):839-42. PubMed ID: 8951903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid stunning.
    Medvedec M
    J Nucl Med; 2001 Jul; 42(7):1129-31. PubMed ID: 11438638
    [No Abstract]   [Full Text] [Related]  

  • 20. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
    Gallowitsch HJ; Kresnik E; Mikosch P; Pipam W; Gomez I; Lind P
    Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.